Birth Outcomes for Pregnant Women With HIV Using Tenofovir-Emtricitabine EDITORIAL COMMENT

被引：0
|
作者：
Norton, Mary E.
机构：
来源：
OBSTETRICAL & GYNECOLOGICAL SURVEY | 2018年 / 73卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：513 / 515
页数：3
相关论文
共 50 条
  • [1] Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine
    Rough, Kathryn
    Seage, George R., III
    Williams, Paige L.
    Hernandez-Diaz, Sonia
    Huo, Yanling
    Chadwick, Ellen G.
    Currier, Judith S.
    Hoffman, Risa M.
    Barr, Emily
    Shapiro, David E.
    Patel, Kunjal
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (17): : 1593 - 1603
  • [2] A retrospective analysis of bone loss in tenofovir-emtricitabine therapy for HIV PrEP
    Chang, Joseph
    Duy Do
    Delgado, Hector
    Kanimian, Natalie
    An Huynh
    INTERNATIONAL JOURNAL OF STD & AIDS, 2022, 33 (14) : 1183 - 1192
  • [3] Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women With HIV: Laboratory and Clinical Outcomes in an Observational National Study
    Floridia, Marco
    Pinnetti, Carmela
    Ravizza, Marina
    Masuelli, Giulia
    Personeni, Carlo
    Sansone, Matilde
    Degli Antoni, Anna
    Guaraldi, Giovanni
    Spinillo, Arsenio
    Tassis, Beatrice
    Dalzero, Serena
    Liuzzi, Giuseppina
    Tamburrini, Enrica
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (01) : 99 - 104
  • [4] Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy
    Sax, Paul E.
    Tierney, Camlin
    Collier, Ann C.
    Fischl, Margaret A.
    Mollan, Katie
    Peeples, Lynne
    Godfrey, Catherine
    Jahed, Nasreen C.
    Myers, Laurie
    Katzenstein, David
    Farajallah, Awny
    Rooney, James F.
    Ha, Belinda
    Woodward, William C.
    Koletar, Susan L.
    Johnson, Victoria A.
    Geiseler, P. Jan
    Daar, Eric S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (23): : 2230 - 2240
  • [5] The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
    Colbers, Angela P. H.
    Hawkins, David A.
    Gingelmaier, Andrea
    Kabeya, Kabamba
    Rockstroh, Juergen K.
    Wyen, Christopher
    Weizsaecker, Katharina
    Sadiq, S. Tariq
    Ivanovic, Jelena
    Giaquinto, Carlo
    Taylor, Graham P.
    Molto, Jose
    Burger, David M.
    AIDS, 2013, 27 (05) : 739 - 748
  • [6] Reduced Immune Activation During Tenofovir-Emtricitabine Therapy in HIV-Negative Individuals
    Castillo-Mancilla, Jose R.
    Meditz, Amie
    Wilson, Cara
    Zheng, Jia-Hua
    Palmer, Brent E.
    Lee, Eric J.
    Gardner, Edward M.
    Seifert, Sharon
    Kerr, Becky
    Bushman, Lane R.
    MaWhinney, Samantha
    Anderson, Peter L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 495 - 501
  • [7] Emtricitabine/tenofovir does not increase adverse birth outcomes
    Reactions Weekly, 2018, 1701 (1) : 10 - 10
  • [8] Virological suppression after use of crushed tenofovir-emtricitabine and dolutegravir tablets in a patient with HIV infection
    Buscemi, Lindsey
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (15) : 1125 - 1126
  • [9] Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine
    Dumond, Julie B.
    Bay, Camden P.
    Nelson, Julie A. E.
    Davalos, Angel
    Edmonds, Andrew
    De Paris, Kristina
    Sykes, Craig
    Anastos, Kathryn
    Sharma, Roopali
    Kassaye, Seble
    Tamraz, Bani
    French, Audrey L.
    Gange, Stephen
    Ofotokun, Ighovwerha
    Fischl, Margaret A.
    Vance, David E.
    Adimora, Adaora A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [10] A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV
    Zhang, Haeyoung
    Hindman, Jason T.
    Lin, Ludwig
    Davis, Maggie
    Shang, Justin
    Xiao, Deqing
    Avihingsanon, Anchalee
    Arora, Priyanka
    Palaparthy, Ramesh
    Girish, Sandhya
    Marathe, Dhananjay D.
    AIDS, 2024, 38 (01) : F1 - F9
12345